Here we provide a selection of scientific publications related to IOZK immunotherapy. You can use the filters to make a selection according to tumor types and methods, or enter search terms.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002024-11-30 / Vet World 2024 Nov;17(11):2688-2693https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2024-11-30 / Vet World 2024 Nov;17(11):2688-26932024-11-30 00:00:002024-11-30 00:00:00The oncolytic effect of Newcastle disease virus attenuated AMHA1 strain against digestive system tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002024-10-29 / Int Immunopharmacol 2024 Dec;143(Pt 2):113481https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2024-10-29 / Int Immunopharmacol 2024 Dec;143(Pt 2):1134812024-10-29 00:00:002024-10-29 00:00:00Synergistic Anti-Tumor Effects of Newcastle Disease Virus and Doxorubicin: Evidence from A Murine Breast Cancer Model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002024-10-16 / Oncol Lett 2025 Jan;29(1):6https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2024-10-16 / Oncol Lett 2025 Jan;29(1):62024-10-16 00:00:002024-10-16 00:00:00Anticancer effect of the oncolytic Newcastle disease virus harboring the PTEN gene on glioblastoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002024-10-10 / BMC Cancer 2024 Oct;24(1):1253https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2024-10-10 / BMC Cancer 2024 Oct;24(1):12532024-10-10 00:00:002024-10-10 00:00:00Newcastle disease virus enhances the antitumor efficacy of Doxorubicin in a cervical cancer mouse model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002024-09-13 / Oncol Lett 2024 Nov;28(5):550https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2024-09-13 / Oncol Lett 2024 Nov;28(5):5502024-09-13 00:00:002024-09-13 00:00:00induction of anti‑lung cancer immune response by the A549 lung cancer stem cell lysate‑sensitized dendritic cell vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002024-08-30 / Front Mol Biosci 2024;11:1331369https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2024-08-30 / Front Mol Biosci 2024;11:13313692024-08-30 00:00:002024-08-30 00:00:00Antimetastatic and antitumor activities of oncolytic NDV AMHA1 in a 3D culture model of breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002024-08-14 / PLoS One 2024;19(8):e0308599https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2024-08-14 / PLoS One 2024;19(8):e03085992024-08-14 00:00:002024-08-14 00:00:00Synergistic cytotoxicity of olive leaf extract-loaded lipid nanocarriers combined with Newcastle disease virus against cervical cancer cells
The Complexity of Malignant Glioma Treatment
WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer
The oncolytic effect of Newcastle disease virus attenuated AMHA1 strain against digestive system tumors
The Synergy of Thermal and Non-Thermal Effects in Hyperthermic Oncology
The future of cellular therapy for the treatment of renal cell carcinoma
Synergistic Anti-Tumor Effects of Newcastle Disease Virus and Doxorubicin: Evidence from A Murine Breast Cancer Model
Newcastle disease virus harboring the PTEN gene inhibits pancreatic cancer growth by inhibiting PI3K/AKT/mTOR signaling and activating apoptosis
IL-12 encoding oNDV synergizes with CAR-T cells in orthotopic models of non-small cell lung cancer
Anticancer effect of the oncolytic Newcastle disease virus harboring the PTEN gene on glioblastoma
Newcastle disease virus enhances the antitumor efficacy of Doxorubicin in a cervical cancer mouse model
Trial watch: anticancer vaccination with dendritic cells
Complete Cure of Inoperable Stage IV Locally Advanced Hypopharyngeal Squamous Cell Carcinoma by an Innovative Combination Cancer Immunotherapy Consisting of Radiation, Immune Checkpoint Inhibitors, and Dendritic Cell Vaccine
induction of anti‑lung cancer immune response by the A549 lung cancer stem cell lysate‑sensitized dendritic cell vaccine
Personalized Dendritic-cell-based Vaccines Targeting Cancer Neoantigens
Antimetastatic and antitumor activities of oncolytic NDV AMHA1 in a 3D culture model of breast cancer
Synergistic cytotoxicity of olive leaf extract-loaded lipid nanocarriers combined with Newcastle disease virus against cervical cancer cells
Combination of Radiation Therapy, Wim’s Tumor 1 (WT1) Dendritic Cell Vaccine Therapy, and α-Galactosylceramide-Pulsed Dendritic Cell Vaccine Therapy for End-Stage Small Bowel Cancer
Newcastle Disease Virus Virotherapy: Unveiling Oncolytic Efficacy and Immunomodulation